Access cutting-edge cognitive impairment treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access cognitive impairment specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cognitive impairment treatment provided free
PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
Sponsor: Duke University
Check if you qualify for this cognitive impairment clinical trial in Birmingham, AL
If you're searching for cognitive impairment treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cognitive impairment specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.